US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist

2.410
-0.150-5.86%

Close Mar 26 16:00 ET

2.410
0.0000.00%

Post 16:05 ET

33.06MMarket Cap-2.10P/E (TTM)

Grace Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Grace Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/Q1	-- / 0.000	--
--	2025/Q4	-- / 0.000	--
--	2025/Q3	0.000 / 0.000	--
--	2025/Q2	0.000 / 0.000	--
--	2025/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2026/Q1-- / 0.000--

--2025/Q4-- / 0.000--

--2025/Q30.000 / 0.000--

--2025/Q20.000 / 0.000--

--2025/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Grace Therapeutics Earnings Reports

Grace Therapeutics | 10-Q/A: Quarterly report (Amendment)

Feb 19 11:45 ET

Grace Therapeutics | 8-K: Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update

Feb 13 08:04 ET

Grace Therapeutics | 10-Q: Q3 2025 Earnings Report

Feb 13 07:34 ET

Grace Therapeutics | 8-K: Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update

Nov 13, 2024 08:02 ET